Metropolitan Life Insurance Company (MetLife)’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,350
| Closed | -$1.81M | – | 1011 |
|
|
2024
Q1 | $1.81M | Sell |
3,350
-33
| -1% | -$18K | 0.08% | 213 |
|
|
2023
Q4 | $1.88M | Sell |
3,383
-52
| -2% | -$24.4K | 0.09% | 196 |
|
|
2023
Q3 | $1.5M | Sell |
3,435
-183
| -5% | -$91.3K | 0.08% | 223 |
|
|
2023
Q2 | $1.82M | Sell |
3,618
-86
| -2% | -$41.2K | 0.09% | 194 |
|
|
2023
Q1 | $1.85M | Sell |
3,704
-991
| -21% | -$474K | 0.1% | 191 |
|
|
2022
Q4 | $1.92M | Sell |
4,695
-141
| -3% | -$54.7K | 0.09% | 232 |
|
|
2022
Q3 | $1.58M | Sell |
4,836
-103
| -2% | -$37.8K | 0.07% | 261 |
|
|
2022
Q2 | $1.73M | Sell |
4,939
-171
| -3% | -$69.7K | 0.08% | 246 |
|
|
2022
Q1 | $2.8M | Sell |
5,110
-8,402
| -62% | -$4.42M | 0.1% | 190 |
|
|
2021
Q4 | $8.9M | Sell |
13,512
-293
| -2% | -$184K | 0.12% | 132 |
|
|
2021
Q3 | $8.59M | Sell |
13,805
-479
| -3% | -$322K | 0.12% | 131 |
|
|
2021
Q2 | $9.02M | Sell |
14,284
-444
| -3% | -$245K | 0.13% | 128 |
|
|
2021
Q1 | $7.21M | Sell |
14,728
-843
| -5% | -$422K | 0.11% | 152 |
|
|
2020
Q4 | $7.78M | Sell |
15,571
-589
| -4% | -$264K | 0.12% | 145 |
|
|
2020
Q3 | $6.35M | Sell |
16,160
-643
| -4% | -$238K | 0.11% | 153 |
|
|
2020
Q2 | $5.55M | Buy |
16,803
+191
| +1% | +$55.3K | 0.1% | 166 |
|
|
2020
Q1 | $4.02M | Sell |
16,612
-238
| -1% | -$62.1K | 0.08% | 196 |
|
|
2019
Q4 | $4.4M | Sell |
16,850
-129
| -0.8% | -$34K | 0.07% | 237 |
|
|
2019
Q3 | $4.62M | Sell |
16,979
-15
| -0.1% | -$4.17K | 0.08% | 227 |
|
|
2019
Q2 | $4.68M | Buy |
16,994
+866
| +5% | +$213K | 0.08% | 222 |
|
|
2019
Q1 | $3.61M | Sell |
16,128
-653
| -4% | -$135K | 0.07% | 247 |
|
|
2018
Q4 | $3.12M | Sell |
16,781
-119
| -0.7% | -$24.4K | 0.06% | 253 |
|
|
2018
Q3 | $4.22M | Sell |
16,900
-425
| -2% | -$103K | 0.07% | 226 |
|
|
2018
Q2 | $3.78M | Buy |
17,325
+62
| +0.4% | +$12.8K | 0.06% | 253 |
|
|
2018
Q1 | $3.3M | Hold |
17,263
| – | – | 0.05% | 296 |
|
|
2017
Q4 | $2.7M | Sell |
17,263
-27,870
| -62% | -$4.39M | 0.04% | 369 |
|
|
2017
Q3 | $7.02M | Sell |
45,133
-959
| -2% | -$152K | 0.04% | 375 |
|
|
2017
Q2 | $7.44M | Sell |
46,092
-826
| -2% | -$134K | 0.05% | 345 |
|
|
2017
Q1 | $7.25M | Sell |
46,918
-40,388
| -46% | -$5.57M | 0.05% | 375 |
|
|
2016
Q4 | $10.2M | Sell |
87,306
-429
| -0.5% | -$49K | 0.07% | 252 |
|
|
2016
Q3 | $9.89M | Sell |
87,735
-397
| -0.5% | -$41.8K | 0.07% | 260 |
|
|
2016
Q2 | $8.18M | Buy |
88,132
+2,490
| +3% | +$214K | 0.06% | 298 |
|
|
2016
Q1 | $6.71M | Buy |
85,642
+1,168
| +1% | +$84.1K | 0.05% | 371 |
|
|
2015
Q4 | $6.16M | Sell |
84,474
-366
| -0.4% | -$26.1K | 0.05% | 403 |
|
|
2015
Q3 | $6.3M | Sell |
84,840
-2,064
| -2% | -$148K | 0.05% | 395 |
|
|
2015
Q2 | $5.57M | Buy |
+86,904
| New | +$6.02M | 0.04% | 478 |
|
|
2015
Q1 | – | Sell |
-84,994
| Closed | -$6.3M | – | 2312 |
|
|
2014
Q4 | $6.3M | Sell |
84,994
-3,824
| -4% | -$268K | 0.04% | 425 |
|
|
2014
Q3 | $5.23M | Sell |
88,818
-1,156
| -1% | -$73.1K | 0.04% | 478 |
|
|
2014
Q2 | $6.01M | Sell |
89,974
-674
| -0.7% | -$42.9K | 0.04% | 452 |
|
|
2014
Q1 | $5.5M | Buy |
90,648
+1,174
| +1% | +$69.9K | 0.04% | 487 |
|
|
2013
Q4 | $4.76M | Sell |
89,474
-678
| -0.8% | -$35.7K | 0.03% | 539 |
|
|
2013
Q3 | $4.49M | Sell |
90,152
-1,470
| -2% | -$70.7K | 0.03% | 531 |
|
|
2013
Q2 | $4.11M | Buy |
+91,622
| New | +$4M | 0.03% | 522 |
|
Other funds holding IDXX
Metropolitan Life Insurance Company (MetLife)'s IDXX Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Idexx Laboratories (IDXX) in Q2 2024, closing a stake of 3,350 shares — an estimated $1.81M sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in IDXX in Q2 2013 and held it in 43 quarters. The position peaked at $10.2M in Q4 2016. 1,110 funds tracked by Wall St. Rank hold IDXX as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Idexx Laboratories position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 3,350 Idexx Laboratories shares in Q2 2024, an estimated $1.81M.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Idexx Laboratories in Q2 2013 and held it in 43 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Idexx Laboratories position peaked at $10.2M in Q4 2016.
- 1,110 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.